The superconducting phase transition in heavy fermion CeCoIn5 (T(c)=2.3 K in zero field) becomes first order when the magnetic field H parallel [001] is greater than 4.7 T, and the transition temperature is below T0 approximately 0.31T(c). The change from second order at lower fields is reflected in strong sharpening of both specific heat and thermal expansion anomalies associated with the phase transition, a strong magnetocaloric effect, and a steplike change in the sample volume. This effect is due to Pauli limiting in a type-II superconductor, and was predicted theoretically in the mid-1960s.
Superconductivity without phonons has been proposed for strongly correlated electron materials that are tuned close to a zero-temperature magnetic instability of itinerant charge carriers. Near this boundary, quantum fluctuations of magnetic degrees of freedom assume the role of phonons in conventional superconductors, creating an attractive interaction that 'glues' electrons into superconducting pairs. Here we show that superconductivity can arise from a very different spectrum of fluctuations associated with a local (or Kondo-breakdown) quantum critical point that is revealed in isotropic scattering of charge carriers and a sublinear, temperature-dependent electrical resistivity. At this critical point, accessed by applying pressure to the strongly correlated, local-moment antiferromagnet CeRhIn(5), magnetic and charge fluctuations coexist and produce electronic scattering that is maximal at the optimal pressure for superconductivity. This previously unanticipated source of pairing glue opens possibilities for understanding and discovering new unconventional forms of superconductivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.